CPT code 64610 designates an image‑guided neurodestructive injection directed at part of the trigeminal nerve. It is used to interrupt sensory or motor function in the face and scalp, most commonly to treat severe trigeminal neuralgia (tic douloureux). Nationally, this procedure is clinically significant because it addresses a debilitating pain syndrome that can require specialized procedural pain management and may affect utilization patterns across outpatient surgical settings.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and common billing modifiers (provided in input). The publication summarizes available benchmarks and payment policy considerations, highlights coding and documentation points relevant to procedural and imaging guidance elements, and outlines implications for utilization management and prior authorization practices. Practical takeaways include how the procedure is described in coding terms, the clinical scenarios that commonly justify its use, and where to look for payer policy updates or medical necessity criteria. Data not available in the input will be noted where relevant.